Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdams Regulatory News (ADA)

  • There is currently no data for ADA

'Clinic' Marketing Update

28 Feb 2005 07:00

DawMed Systems PLC28 February 2005 FOR IMMEDIATE RELEASE 28 FEBRUARY 2005 DAWMED SYSTEMS PLC ("DawMed" or "the Company") 'CLINIC' MARKETING UPDATE 'CLINIC' BENCH TOP WASHER-DISINFECTOR-DRYER INTRODUCED TO US$74 BILLION MIDDLE EAST HEALTHCARE MARKET According to published results by the UK Department of Health relating toSecondary Healthcare hospital decontamination services for surgical instrumentsin the NHS, more effective decontamination was identified as a key component toachieve higher quality surgical care, and a programme to bring such services upto the required standard was completed last year. According to the NationalAudit Office, it has been estimated that some 5,000 people currently die eachyear from hospital-acquired infections. The Board of DawMed, the medical devices company which designs, manufactures,sells and services washer-disinfector-dryers ("WDD") used by NHS Trusthospitals, private hospitals and clinics, reports the noticeably high level ofinterest in its unique and innovative 'Clinic' - a key driver in the Company'slong term growth strategy - which was exhibited by the Company last week at theArab Health Exhibition, the Middle East's largest healthcare exhibition, inDubai. The Clinic WDD is designed for use in the Primary Healthcare sector (i.e.doctors, dentists, endodontists, clinicians, et al) as well as for certaindepartments of Secondary Healthcare hospitals. DawMed has successfullyincorporated all the technology of its large WDD equipment by miniaturisationinto a machine size comparable with bench top sterilisers, which proliferatethroughout the Primary Healthcare sector worldwide. The Clinic fits perfectly into the existing surgical instrument decontaminationprocess by replacing manual and/or ultrasonic cleaning procedures in favour of afully automatic procedure which is also fully compliant with UK guidelines andimminent European standards. It features a 'Watchdog' microprocessor controlsystem that will detect and alarm under fault conditions. Now, in its 30th year, the Arab Health Exhibition is the largest healthcareevent in the Middle East and one of the most important in the world today. Withthe Middle East healthcare market valued at US$74 billion annually, the eventhas been attracting more and more exhibitors and visitors each year. In 2004, atotal of 1,422 exhibitors from 50 countries, including 25 national countrypavilions displayed their healthcare products and services to over 30,000visitors. The visitors included over 4,400 dealers and distributors. Whilst there are estimated to be around 40,000 bench top sterilisers in use inPrimary Healthcare in the UK, the vast majority of these are currently notaccompanied by a WDD, but should be. Instead, technicians and nurses typicallywash and dry surgical instruments manually before placing them in sterilisers,thereby risking cross-infection of themselves as well as patients and alsocompromising the desired effect of sterilisation. DawMed's management believesthat the Clinic has a number of unique features and functional advantages overcompetitors' products. These include: • Double door option: An important facility that is unique to the Clinicenables the "pass through" principle to be operated. As a result the unit can beinstalled through a partition or wall, thus creating a physical barrier betweenthe clean and the dirty sides of the partition or between the clean and dirtyrooms - a technique always employed by hospital Sterile Service Departments orCentral Decontamination Units to avoid confusion as to which instruments areclean and which are dirty. The double door option also constitutes a fail-safefeature whereby if one door is open, the other is locked; • Accurate dosing and performance monitoring: An important facility thatensures that the precise amount of detergent is used with each wash - if theright quantity is not used (for example if the container is damaged), then theoperator will be warned that the process has deliberately failed on thefail-safe principle. The system will also monitor and deliberately fail-safe ifimportant problems occur, for example incorrect length of process, incorrecttemperature attainment and incorrect pump pressure; • Forced air drying: An important facility that is unique to the Clinic andwhich enables immediate transfer of the surgical instruments into thesteriliser. It is not possible to sterilise a surgical instrument if it is wetand the use of towels for drying is highly likely to re-contaminate it; and • Standards compliance: DawMed's management believes the Clinic is the onlybench top WDD in the world which is fully compliant with the current UKguidelines (HTM 2030) and imminent European/UK standards (pr/EN 15883 Parts 1and 2). DawMed has invested heavily in the bespoke design and development of its Clinicproduct range, and has already received two SMART awards for productdevelopment; the Company intends to continue to focus on marketing the Clinic tofurther its application to affinity markets. Commenting on the Clinic and its potential market, Kevin Gilmore, ExecutiveChairman, said: "The project for the development of Clinic started four years ago, aftermanagement predicted that NHS would extend the UK and imminent Europeanstandards of decontamination of surgical instruments, which already applied toSecondary Healthcare hospitals, to the Primary Healthcare sector. The NHS havenow done so, effective from February 2005. "The Clinic is small, fast and easy to use. Its size is comparable with benchtop sterilisers and it is currently being supplied to the Primary Healthcaremarket and other emerging niche markets. "The wider market for the Clinic, which is now open to exploitation by DawMed,includes the whole of the European Common Market (larger than the USA at some350 million people) as well as the USA, the growing economies of Asia, India andChina and, eventually, the rest of the world." Commenting on the Exhibition and the likely sources of cross infection, JohnCrispin, Managing Director, said: "Exhibiting the Clinic at the Arab Health Exhibition was a logical step in ourmarketing programme. DawMed's directors believe that the Clinic is the mostadvanced bench top washer-disinfector-dryer in today's worldwide market place,and we look to the future of the product with confidence. "Although there is no reliable information available as to the number, severityor consequences of cross infections arising from surgical procedures carried outin Primary Healthcare, there can be no doubt that the greatest number, and thegreatest increase in numbers of such procedures, take place in PrimaryHealthcare. It may therefore be reasonably argued that a major risk of crossinfections through surgical procedures originates in Primary Healthcare. " ---ends--- Enquiries: DawMed Systems plc Tel: 01789 450075 Kevin Gilmore, Executive Chairman Beaumont Cornish limited Tel: 020 7628 3396Roland Cornish Bishopsgate Communications Limited Tel: 020 7430 1600Maxine Barnes, Dominic Barretto For further information about DawMed please visit our website at www.dawmed.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Dec 20247:00 amRNSCancellation - Adams Plc
28th Nov 20247:01 amRNSResult of Extraordinary General Meeting
28th Nov 20247:00 amRNSHalf-year Report
25th Oct 20247:00 amRNSProposed Cancellation of Admission
13th Sep 20244:19 pmRNSResult of AGM
27th Jun 20247:00 amRNSFinal Results
20th Dec 202310:15 amRNSHolding(s) in Company
23rd Nov 20237:00 amRNSHalf-year Report
26th Sep 20234:03 pmRNSHolding(s) in Company
18th Aug 20233:33 pmRNSResult of AGM
16th Aug 20231:04 pmRNSHolding(s) in Company
15th Aug 20233:37 pmRNSHolding(s) in Company
14th Jul 20237:00 amRNSFinal Results
9th Mar 20233:47 pmRNSAnnouncement by WANdisco
18th Jan 202312:00 pmRNSHolding(s) in Company
17th Jan 20234:18 pmRNSHolding(s) in Company
24th Nov 20227:00 amRNSHalf-year Report
26th Aug 20223:44 pmRNSResult of AGM
7th Jul 20227:00 amRNSFinal Results
26th Nov 20217:00 amRNSHalf-year Report
26th Aug 202111:29 amRNSResult of AGM
28th Jun 20217:00 amRNSFinal Results
27th May 20217:00 amRNSInvestment in Motif Bio Plc
7th May 202111:33 amRNSHolding(s) in Company
7th May 202111:30 amRNSHolding(s) in Company
7th May 20217:00 amRNSInvestment in Seeing Machines Limited
15th Apr 202112:48 pmRNSResult of Open Offer
26th Mar 20217:00 amRNSPlacing and Open Offer
26th Nov 20207:00 amRNSHalf-year Report
22nd Oct 202010:23 amRNSInvestment Commitment in C4X Discovery Holdings
21st Aug 202012:45 pmRNSResult of AGM
30th Jun 20207:00 amRNSFinal Results
19th Jun 20203:24 pmRNSAssignment of Shareholder Loan Facility
12th Jun 20204:41 pmRNSSecond Price Monitoring Extn
12th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20207:00 amRNSInvestment
19th Mar 20203:41 pmRNSStatement re COVID-19
11th Mar 20209:41 amRNSChange of Registered Office
3rd Jan 20207:00 amRNSInvestment
17th Dec 20198:57 amRNSDisposal
28th Nov 20197:00 amRNSHalf-year Report
9th Aug 201911:59 amRNSResult of AGM
3rd Jul 20197:00 amRNSFinal Results
29th Jan 20191:26 pmRNSShareholder Loan
27th Nov 20187:00 amRNSHalf-year Report
10th Aug 20182:01 pmRNSResult of AGM
26th Jun 20187:03 amRNSChange of Currency and AGM Proposals
26th Jun 20187:00 amRNSFinal Results
4th Jun 20189:56 amRNSHolding(s) in Company
4th Jun 20189:48 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.